Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion type Assertion NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_head.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion description "[Although much progress has been made in understanding the molecular pathogenesis of myeloid neoplasms, most of the diseases included in the group of MDS/MPN still remain 'clinicopathologically assigned'.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_provenance.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion evidence source_evidence_literature NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_provenance.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion SIO_000772 18480833 NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_provenance.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion wasDerivedFrom befree-20150227 NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_provenance.
- NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_assertion wasGeneratedBy ECO_0000203 NP978672.RAHpTv-_DN0FVSSX-zp3DchdKDHEHskiakaNsFgdddT3A130_provenance.